Clinical Trials Logo

Dry Skin clinical trials

View clinical trials related to Dry Skin.

Filter by:

NCT ID: NCT05982535 Completed - Dry Skin Clinical Trials

Neopep-S Ingredient Easy Dew MD Regen Cream

Start date: November 11, 2022
Phase: N/A
Study type: Interventional

The purpose of this clinical study is to provide patients diagnosed with dry skin due to various causes such as atopic dermatitis and Yangjin The effect on skin regeneration after applying EasyDew MD Regen Cream containing Neopep-S, a regeneration factor, and It is intended to assess safety.

NCT ID: NCT05972512 Recruiting - Dry Skin Clinical Trials

A Clinical Study to Assess the Safety and Effectiveness of Plant-based Biotin and Plant Based Biotin With Silica in Healthy Human Subjects With Complaints of Hair Fall, Thin, Dry, & Brittle Hair, and Dry Skin

Start date: October 24, 2023
Phase: N/A
Study type: Interventional

A randomized, double-blind, three-arm, placebo-controlled, safety, and efficacy study of plant-based Biotin and plant-based Biotin with Silica in healthy adult human subjects with complaints of hair fall, thin, dry, and brittle hair, and dry skin. A sufficient number (maximum of 105 (35 subject/test treatment)) of female/male adult subjects will be recruited/enrolled to ensure a total of 96 subjects (32 subjects/test treatment) complete the study.

NCT ID: NCT05872113 Completed - Dry Skin Clinical Trials

Evaluation of Human Efficacy for Skin Moisturization and Wrinkle Improvement

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

All subjects used the placebo sample on the left side of their face and the investigational sample on the right side of their face, respectively. The moisturizing levels were detected before use (0 week), after 2 weeks and after 4 weeks. The wrinkles of subjects were also measured on the same date interval as the skin moisture level test.

NCT ID: NCT05646953 Completed - Healthy Clinical Trials

Safety and Efficacy Study of Vasu Facial Beauty Oil

Start date: January 6, 2023
Phase: N/A
Study type: Interventional

This is an open-label, single-arm, single-center, proof-of-concept, exploratory, safety and efficacy, clinical study of a Vasu Facial Beauty Oil in healthy adult human subjects. Considering the proof of concept study, a sufficient number [maximum of 32 subjects (25 females and 7 males)] of adult subjects will be recruited/enrolled to ensure a total of 30 subjects complete the study. The potential subjects will be screened as per the inclusion & exclusion criteria only after obtaining written informed consent from the subjects. The total clinical study duration is 60 Days from Day 01.

NCT ID: NCT05059197 Completed - Dry Skin Clinical Trials

Efficacy and Safety of AP Collagen Peptide on the Skin

Start date: December 15, 2020
Phase: N/A
Study type: Interventional

This double-blinded, randomized, placebo-controlled study aimed to evaluate the efficacy and safety of AP collagen peptides (APCP) containing 3% Glycine-Proline-Hydroxyproline (GPH) on improving skin health. Subjects with dried skin were randomly assigned to receive placebo or APCP once daily for 12 weeks.

NCT ID: NCT05013645 Active, not recruiting - Dry Skin Clinical Trials

Evaluation of Skin Hydration in Adults With Dry Skin Using a Moisturizer With an Added Sterilized Probiotic

DAMP
Start date: May 22, 2019
Phase: N/A
Study type: Interventional

Double-blind placebo-controlled clinical trial to evaluate the effectiveness of a sterilized probiotic on skin health and hydration in adults with dry skin. The goal of the study is to determine if the addition of a skin-conditioning probiotic to a standard gel product will moisturize the skin, support a healthy skin microbiome, and be readily tolerated by adults with dry skin.

NCT ID: NCT04085809 Completed - Dry Skin Clinical Trials

This Was a Clinical Study Investigating the Moisturization and Desquamation Effect of AmLactin® Rapid Relief Restoring Lotion + Ceramides on Dry Skin in Healthy Female Volunteers. AmLactin® Rapid Relief is an Over-the-counter Cosmetic

Start date: March 26, 2019
Phase: N/A
Study type: Interventional

The primary objective of this study was to investigate if AmLactin® Rapid Relief improves the skin through desquamation and moisturization via D-SQUAME analysis. AmLactin® Rapid Relief is an over-the-counter cosmetic.

NCT ID: NCT03824886 Completed - Pressure Ulcer Clinical Trials

Enhancing SKIN Health and Safety in Aged CARE

SKINCARE
Start date: October 1, 2018
Phase: N/A
Study type: Interventional

Aged long-term care receivers are affected by various adverse skin conditions like pressure ulcers, incontinence-associated dermatitis, dryness, intertrigo and many more. Prevention of these skin problems and the provision of general hygiene and skin care activities are key areas of nursing practice. Numerous condition specific guidelines are available and are implemented separately. The more guidelines exist, the more difficult it is for nurses to implement them all. On the other hand, there is a huge overlap in terms of aetiology, pathogenesis and prevention of aforementioned skin conditions. The overall aim of this trial is to test the feasibility and to estimate possible effects of a comprehensive skin care package targeting main nursing relevant skin problems at the same time. Therefore a study will be performed in nursing homes of the state of Berlin comparing the skin care package to standard care. Residents' safety and subjective wellbeing will increase combined with improvements in professional competence of nurses. An advisory board consisting of international experts agreed already to supervise the trial.

NCT ID: NCT03804710 Completed - Skin Care Clinical Trials

To Evaluate the Effect of Moisturizing Creams on Skin Barrier Function

Start date: January 22, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the impact of twice-daily topical application of two different moisturizing creams on skin barrier function for 4 weeks.

NCT ID: NCT01305057 Completed - Dry Skin Clinical Trials

Efficacy Test on Skin Hydration and Skin Barrier Function

Start date: February 2009
Phase: N/A
Study type: Interventional

The effects of topically applied pyridoxine tri-isopalmitate (P-IP) which stimulates filaggrin synthesis in keratinocytes, on skin hydration and barrier function were examined. Subjects were separated into two groups to examine the effect of P-IP. Subjects were treated with P-IP formulation on one side of the face and with a placebo formulation on the other side twice daily (morning and evening) for 28 days. All subjects gave written informed consent prior to the study. The skin hydration and TEWL (transepidermal water loss) were evaluated by measuring skin surface conductance with a skin hygrometer SKICON 200EX (I.B.S. ltd., Japan) and TEWL meter AS-CT1 (ASAHI BIOMED, Tokyo, Japan), respectively.